Johnson & Johnson and its subsidiary Janssen Pharmaceuticals have agreed to settle Topamax birth defect lawsuits. Plaintiffs alleged that Topamax epilepsy drug side effects birth defects including cleft lips, cleft palates and other congenital malformations.
The Topamax global settlements were announced last week in Pennsylvania state court, stating that agreements have been reached in 76 complaints. According to a report, the drug manufacturers are exposed to face at least 60 additional cases that are centralized in Philadelphia.
State Court Bellwether Trials